Good result. Market share still increasing (11.9% vs 11.2% pcp) and on track for forward P/E of about 5.5 at current price (51cps). Debt creeping down, yield creeping up. Looks sleepy but safe.
- Forums
- ASX - By Stock
- CKL
- Ann: Half Yearly Report
Ann: Half Yearly Report , page-2
Featured News
Add CKL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online